Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression-Reference-Cited by-同舟云学术

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression

Published:2021-05-11 Issue:4 Volume:25 Page:409-424
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Pellegrino Benedetta^ORCID,Hlavata Zuzana,Migali Cristina,De Silva Pushpamali,Aiello Marco,Willard-Gallo Karen,Musolino Antonino,Solinas Cinzia

Funder

Università degli Studi di Parma

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40291-021-00525-7.pdf

Reference144 articles.

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

3. Public Health England (PHE). Survival by stage. Stage Break by CCG 2016. 2018. http://www.ncin.org.uk/publications/survival_by_stage. Accessed 24 Apr 2020.

4. Cancer | Detect Cancer Early | Health Topics | ISD Scotland. https://www.isdscotland.org/Health-Topics/Cancer/Detect-Cancer-Early/. Accessed 24 Apr 2020.

5. Queen’s University Belfast. Queen’s University Belfast | N. Ireland Cancer Registry | Official Statistics. N. Irel. Cancer Regist. https://www.qub.ac.uk/research-centres/nicr/CancerInformation/official-statistics/. Accessed 24 Apr 2020.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histogram analysis comparison of readout-segmented and single-shot echo-planar imaging for differentiating luminal from non-luminal breast cancer;Scientific Reports;2024-05-27

2. Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer;Cancer Management and Research;2024-05

3. Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies;Journal of Pharmacy and Pharmacology;2024-04-23

4. Clustering of HR + /HER2− breast cancer in an Asian cohort is driven by immune phenotypes;Breast Cancer Research;2024-04-22

5. Racial and socioeconomic disparities in triple-negative breast cancer treatment;Expert Review of Anticancer Therapy;2024-03-11